Centre Hospitalier Universitaire Amiens Picardie

25 trials 11 recruiting Academic / non-commercial

Filter these 25 trials by condition, phase, country and more.

Open in Search →

25 Registered trials

11 Recruiting

2 Completed trials

1 Countries active

63 Unique IMPs

100% Results reported

Phase III

Phase IV

Phase III: 14 Phase II: 1 Phase III/IV: 2 Phase IV: 8

100%

2 of 2 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top IMPs

SODIUM CHLORIDE 3 ADALIMUMAB 2 ETHAMBUTOL HYDROCHLORIDE 2 MORPHINE SULFATE 2 ALTEPLASE 1 AMIKACIN 1 AMOXICILLIN, CLAVULANIC ACID 1 ANHYDROUS LIDOCAINE HYDROCHLORIDE 1 AZATHIOPRINE 1 AZITHROMYCIN 1 BUPIVACAINE HYDROCHLORIDE, ANHYDROUS 1 CASPOFUNGIN 1

All trials — page 2

25 total

Does high-dose vitamin B3 supplementation prevent major adverse kidney events during septic shock? A multicenter randomized controlled study Ended

2024-517055-13-00 Phase III 1 country NICOTINAMIDE; SODIUM CHLORIDE

Showing 25–25 of 25 trials

← All sponsors A–Z